Adrien Latgé

Metabolic Response to BRAF-MEK Combination Therapy in Cecal Neuroendocrine Carcinoma With BRAFV600E Mutation and Refractory Lactic Acidosis.

B. Goichot, G. Malouf, A. Imperiale, 2018, Clinical nuclear medicine.

Dual-Time-Point 18F-Fluorocholine PET/CT Improves Characterization of Thyroid Nodules in Patients Referred for Primary Hyperparathyroidism

M. Vix, F. Hubelé, A. Imperiale, 2021, Clinical nuclear medicine.

64CuCl2 PET Imaging of 4T1-Related Allograft of Triple-Negative Breast Cancer in Mice

A. Ouadi, A. Imperiale, F. Boisson, 2022, Molecules.

Impact of pelvic dynamic acquisition on final reading of 18F‐Fluorocholine positron emission tomography in patients with prostate adenocarcinoma: True need or unnecessary burden?

A. Imperiale, F. Somme, F. Séverac, 2021, Journal of medical imaging and radiation oncology.

18F-Fluorocholine PET and 4D-CT in Patients with Persistent and Recurrent Primary Hyperparathyroidism

M. Vix, A. Imperiale, G. Treglia, 2021, Diagnostics.

Does 18F-Fluorocholine PET/CT add value to positive parathyroid scintigraphy in the presurgical assessment of primary hyperparathyroidism?

M. Vix, A. Piccardo, A. Imperiale, 2023, Frontiers in Medicine.

Diffuse Bone Uptake of 131I and Effect on Blood Counts in a Patient With Papillary Thyroid Carcinoma and Chronic Lymphocytic Leukemia.

Adrien Latgé, Mehdi Krim, Lavinia Vija, 2024, Clinical nuclear medicine.